Speaking at a presentation of the company’s financial results today that saw it grow profit of €14.8m on a 21.6% increase in revenue to €226.3m from €186.1m in 2009, president and chief executive officer Jacques Dikansky told Shane Starling about the firm’s investment plans.
“In 2011 we expect strong organic growth for the group and we also have a few acquisition projects ongoing. We expect to finalise something during the second half of the year. We have projects of acquisition – companies … in natural ingredients for the food industry, nutraceutical or cosmetic applications.”
“We have companies in view between €5-20m in Europe, the US and other parts of the world.”
Dikansky said the company and the botanical extracts sector was benefitting from an explosion in demand in emerging economies and that the integration of Natraceutical was complete.
“We have opened a lot of sales offices in these markets and we will think about establishing production or acquiring production companies in these countries also.”